[Effects of D-methionine on the hematopoietic system injury in irradiated mice]

De-Guan Li1, Jun-Ling Zhang1, Hong-Ying Wu1

  • 1Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College; Tianjin Key Laboratory of Molecular Nuclear Medicine, Tianjin 300192, China.

Insights

D-methionine (D-met) mitigates radiation-induced hematopoietic injury in mice. It enhances bone marrow cell survival and promotes hematopoietic function recovery after irradiation.

Area of Science:

  • Radiation Biology
  • Hematology
  • Pharmacology

Context:

  • Ionizing radiation exposure causes significant hematopoietic system damage.
  • Radiation-induced hematopoietic injury impacts bone marrow cell survival and function.
  • Investigating radioprotective agents is crucial for mitigating radiation effects.

Purpose:

  • To evaluate the efficacy of D-methionine (D-met) in ameliorating radiation-induced hematopoietic injury in mice.
  • To assess D-met's effects on survival rates, bone marrow cell viability, and hematopoietic progenitor cell function post-irradiation.

Summary:

  • D-methionine administration did not significantly improve overall mouse survival after high-dose irradiation (7.5 Gy).
  • However, D-met significantly increased bone marrow cell survival rates across various irradiation doses (1, 4, 8 Gy).
  • D-met promoted colony-forming unit-granulocyte-macrophage (CFU-GM) counts, indicating enhanced hematopoietic progenitor cell recovery.

Impact:

  • D-methionine demonstrates radioprotective potential by mitigating marrow cell injury.
  • D-met enhances bone marrow cell survival and aids in the recovery of hematopoietic function following radiation exposure.
  • These findings suggest D-met as a potential therapeutic agent for radiation-induced hematopoietic damage.

Related Concept Videos